Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): A non-randomised, open-label trial
Jürgen K. Rockstroh, Mark Nelson, Christine Katlama, Jay Lalezari, Josep Mallolas, Mark Bloch, Gail V. Matthews, Michael S. Saag, Philippe J. Zamor, Chloe Orkin, Jacqueline Gress, Stephanie Klopfer, Melissa Shaughnessy, Janice Wahl, Bach Yen T. Nguyen, Eliav Barr, Heather L. Platt, Michael N. Robertson, Mark Sulkowski
Dive into the research topics of 'Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): A non-randomised, open-label trial'. Together they form a unique fingerprint.